Gwendolyn Binder, President, Science & Technology at Cabaletta Bio, Inc. (CABA), bought 11,312 shares at $2.19 ($25K) on 2026-01-21, disclosed to the SEC on 2026-01-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CABA | SELL | 2023-11-21 | $392K | — | Filing → |
| CABA | SELL | 2023-10-19 | $288K | — | Filing → |
| CABA | SELL | 2023-09-20 | $193K | — | Filing → |